wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38707841-814FE3A3-F417-4FC0-804C-9B04666AFA2F
Q38707841-814FE3A3-F417-4FC0-804C-9B04666AFA2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38707841-814FE3A3-F417-4FC0-804C-9B04666AFA2F
Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.
P2860
Q38707841-814FE3A3-F417-4FC0-804C-9B04666AFA2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38707841-814FE3A3-F417-4FC0-804C-9B04666AFA2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
647e4353865cdd2f5903793fd354006f57f4fdf4
P2860
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.